Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00870324 · ClinicalTrials.gov registry record

OptiSense™ Performance in Detecting Atrial Episodes

A clinical trial of Atrial Fibrillation and Tachyarrhythmias, sponsored by Abbott Medical Devices.

Completed
Registry status
50
Enrollment target
2
Study locations

NCT00870324 is a study of Atrial Fibrillation and Tachyarrhythmias that has completed, run by Abbott Medical Devices. The registered enrollment target is 50 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00870324, a study of Atrial Fibrillation and Tachyarrhythmias, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
50 participants
Enrollment target
2
Study locations

Study Summary

The SENSE-AF study aims to determine the performance of the OptiSense lead in sensing fine episodes of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) and rejecting Far-Field R Wave (FFRW). The performance of the lead will be measured as a difference in device-determined time in AT/AF and surface-ECG determined time in AT/AF. This measurement will be compared to the control group which will be randomized to receive SJM's Tendril™ RA leads.

Conditions Studied

Atrial Fibrillation Tachyarrhythmias

Interventions

  • DEVICE OptiSense Lead
  • DEVICE Tendril Lead

Study Locations (2)

Ohio

  • Northeast Ohio Cardiovascular Specialists - Akron
  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2009-03
Est. Completion 2010-09

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00870324

The ClinicalTrials.gov registry entry for NCT00870324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which OptiSense Lead is the first listed.

NCT00870324 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00870324 about?

NCT00870324 is a clinical study titled "OptiSense™ Performance in Detecting Atrial Episodes". The SENSE-AF study aims to determine the performance of the OptiSense lead in sensing fine episodes of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) and rejecting Far-Field R Wave (FFRW). The performance of the lead will be measured as a difference in device-determined time in AT/AF and surface...

What is the current status of trial NCT00870324?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-03. Estimated completion is 2010-09.

What conditions does trial NCT00870324 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Tachyarrhythmias.

What interventions are being tested in trial NCT00870324?

The interventions under investigation include: OptiSense Lead (DEVICE), Tendril Lead (DEVICE).

Who is sponsoring clinical trial NCT00870324?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00870324 being conducted?

This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Tachyarrhythmias

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.